Reclast, the first once-a-YEAR bisphosphonate infusion for postmenopausal osteoporosis

September 2007

Women will be asking about Reclast, the first once-a-YEAR bisphosphonate infusion for postmenopausal osteoporosis.

Reclast (zoledronic acid) is already approved for Paget's disease. Zoledronic acid is also what's in Zometa for cancer patients.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote